TROMBETTA, Maddalena
 Distribuzione geografica
Continente #
EU - Europa 5.549
NA - Nord America 4.910
AS - Asia 3.314
SA - Sud America 523
AF - Africa 87
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.396
Nazione #
US - Stati Uniti d'America 4.789
RU - Federazione Russa 2.223
GB - Regno Unito 1.491
SG - Singapore 1.304
CN - Cina 991
BR - Brasile 425
IT - Italia 362
SE - Svezia 290
DE - Germania 283
HK - Hong Kong 282
VN - Vietnam 273
FR - Francia 234
FI - Finlandia 227
IE - Irlanda 200
KR - Corea 126
CA - Canada 62
IN - India 57
JP - Giappone 51
UA - Ucraina 49
MX - Messico 43
ID - Indonesia 41
AR - Argentina 39
PK - Pakistan 39
PL - Polonia 33
BD - Bangladesh 32
NL - Olanda 30
TR - Turchia 29
ZA - Sudafrica 24
AT - Austria 23
BE - Belgio 18
EC - Ecuador 16
GR - Grecia 14
IQ - Iraq 14
BJ - Benin 12
ES - Italia 12
UZ - Uzbekistan 11
CZ - Repubblica Ceca 9
EG - Egitto 9
PY - Paraguay 9
VE - Venezuela 9
AU - Australia 8
CL - Cile 8
DZ - Algeria 7
GH - Ghana 7
IR - Iran 7
MA - Marocco 7
SA - Arabia Saudita 7
TG - Togo 7
AZ - Azerbaigian 6
CO - Colombia 6
LT - Lituania 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CR - Costa Rica 5
JO - Giordania 5
KG - Kirghizistan 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
NO - Norvegia 4
TN - Tunisia 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
IL - Israele 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
PE - Perù 3
RS - Serbia 3
TH - Thailandia 3
AL - Albania 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BY - Bielorussia 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
HR - Croazia 1
ML - Mali 1
MY - Malesia 1
NI - Nicaragua 1
Totale 14.386
Città #
Southend 1.336
Dallas 841
Moscow 812
Ashburn 654
Singapore 576
Chandler 543
Jacksonville 322
Hong Kong 278
Woodbridge 234
Beijing 224
Ann Arbor 208
Dublin 200
New York 170
Houston 160
Verona 118
Los Angeles 104
The Dalles 95
Ho Chi Minh City 88
Wilmington 84
Helsinki 79
Lawrence 78
Princeton 78
Jinan 67
Munich 66
Nanjing 54
Seoul 52
Santa Clara 48
Shenyang 45
Buffalo 42
Hanoi 42
Tokyo 42
Boardman 41
Turku 41
Dong Ket 36
Falkenstein 35
Redondo Beach 35
São Paulo 35
Milan 30
Sindelfingen 29
Warsaw 29
Tianjin 28
Hebei 26
Redmond 26
London 25
Columbus 24
Jakarta 24
Zhengzhou 24
Frankfurt am Main 22
Montreal 22
Nanchang 21
Rio de Janeiro 21
Lancaster 20
Bologna 19
Phoenix 19
Romola 19
Brussels 18
Hangzhou 18
Brooklyn 17
Mianwali 17
Nuremberg 17
Council Bluffs 16
Denver 16
Orem 16
Taiyuan 16
Changsha 15
Dearborn 15
Haikou 15
Kent 15
Stockholm 15
Vienna 15
Brasília 14
Chicago 14
San Francisco 14
Toronto 14
Washington 14
Atlanta 13
Haiphong 13
Johannesburg 13
Redwood City 13
Shanghai 13
Boston 12
Chennai 12
Cotonou 12
Mexico City 12
Taizhou 12
Dongguan 11
Guangzhou 11
Hyderabad 11
Poplar 11
Seattle 11
Tashkent 11
Amsterdam 10
Jiaxing 10
Manchester 10
Querétaro 10
San Jose 10
Ankara 9
Ningbo 9
Cagliari 8
Nikaia 8
Totale 8.977
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 750
Common Variants Associated to Type 2 Diabetes in the Italian Population 462
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 230
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 203
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 199
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 197
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 197
Abstracts of 51st EASD Annual Meeting 196
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 192
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 188
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 185
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 185
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 184
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 183
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 180
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 180
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 178
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 177
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 175
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 174
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 174
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 174
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 173
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 172
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 172
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 172
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 169
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 168
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 167
Beta-cell function across the spectrum of glucose tolerance in obese youth. 165
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 163
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 162
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 160
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 159
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 156
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 154
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 154
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 152
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 150
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 150
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 149
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 149
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 149
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 149
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 146
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 144
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 143
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 143
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 141
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 138
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 138
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 137
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 136
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 133
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 133
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 132
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 132
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 131
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 131
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 127
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 125
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 124
Evaluating endothelial function of the common carotid artery: An in vivo human model. 122
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 120
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 115
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 113
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 112
A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 110
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 109
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 108
Continuous subcutaneous insulin infusion in Italy: third national survey. 108
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 108
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 108
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 105
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 104
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 104
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 102
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 102
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 101
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 100
Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report 100
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 98
Methods to assess in vivo insulin sensitivity and insulin secretion 97
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 96
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 96
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 95
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 95
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 93
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 89
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 88
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 86
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 85
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 84
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 82
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 79
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 79
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 70
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 68
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. 64
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 61
Totale 14.567
Categoria #
all - tutte 45.408
article - articoli 32.346
book - libri 0
conference - conferenze 12.714
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 348
Totale 90.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021394 0 0 0 0 0 80 25 44 59 39 65 82
2021/2022664 82 154 19 55 23 36 13 32 24 18 54 154
2022/20231.427 101 196 120 255 130 323 17 80 139 14 34 18
2023/20241.308 36 61 74 102 100 217 32 308 10 130 164 74
2024/20252.367 96 134 114 449 97 90 152 79 389 137 213 417
2025/20265.556 461 522 774 1.431 1.933 435 0 0 0 0 0 0
Totale 14.646